152 related articles for article (PubMed ID: 20807377)
1. The effect and mechanism of action of carbocysteine on airway bacterial load in rats chronically exposed to cigarette smoke.
Sun L; Tang L; Xu Y; Wang S; Li Y; Kang J
Respirology; 2010 Oct; 15(7):1064-71. PubMed ID: 20807377
[TBL] [Abstract][Full Text] [Related]
2. Effect of Myrtol standardized on mucus hypersecretion and clearance of Pseudomonas aeruginosa in a rat model of chronic obstructive pulmonary disease.
Cao L; Chen Y; Zhao Y; Zhang H; Wang S; Wang Z; Kang J
Arzneimittelforschung; 2011; 61(12):685-92. PubMed ID: 22282955
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of clearance of nontypeable Haemophilus influenzae from cigarette smoke-exposed mouse lungs.
Gaschler GJ; Zavitz CC; Bauer CM; Stämpfli MR
Eur Respir J; 2010 Nov; 36(5):1131-42. PubMed ID: 20413532
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the activity of the carbocysteine-sobrerol combination on mucus spinnability.
Distefano SM; Palermo F; Crimi N; Mistretta A; Pamparana F; Messa A
Int J Clin Pharmacol Res; 1988; 8(1):31-5. PubMed ID: 3284830
[TBL] [Abstract][Full Text] [Related]
5. The pharmacologic approach to airway clearance: mucoactive agents.
Rubin BK
Respir Care; 2002 Jul; 47(7):818-22. PubMed ID: 12088552
[TBL] [Abstract][Full Text] [Related]
6. Modulating effects of mucoregulating drugs on the attachment of Haemophilus influenzae.
Ndour CT; Ahmed K; Nakagawa T; Nakano Y; Ichinose A; Tarhan G; Aikawa M; Nagatake T
Microb Pathog; 2001 Mar; 30(3):121-7. PubMed ID: 11273737
[TBL] [Abstract][Full Text] [Related]
7. The role for S-carboxymethylcysteine (carbocisteine) in the management of chronic obstructive pulmonary disease.
Hooper C; Calvert J
Int J Chron Obstruct Pulmon Dis; 2008; 3(4):659-69. PubMed ID: 19281081
[TBL] [Abstract][Full Text] [Related]
8. Cigarette smoke total particulate matter increases mucous secreting cell numbers in vitro: a potential model of goblet cell hyperplasia.
Haswell LE; Hewitt K; Thorne D; Richter A; Gaça MD
Toxicol In Vitro; 2010 Apr; 24(3):981-7. PubMed ID: 20060463
[TBL] [Abstract][Full Text] [Related]
9. Characteristic comparison of three rat models induced by cigarette smoke or combined with LPS: to establish a suitable model for study of airway mucus hypersecretion in chronic obstructive pulmonary disease.
Nie YC; Wu H; Li PB; Luo YL; Zhang CC; Shen JG; Su WW
Pulm Pharmacol Ther; 2012 Oct; 25(5):349-56. PubMed ID: 22732689
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress and innate immunity responses in cigarette smoke stimulated nasal epithelial cells.
Pace E; Ferraro M; Di Vincenzo S; Gerbino S; Bruno A; Lanata L; Gjomarkaj M
Toxicol In Vitro; 2014 Mar; 28(2):292-9. PubMed ID: 24269501
[TBL] [Abstract][Full Text] [Related]
11. Oral N-acetylcysteine or S-carboxymethylcysteine inhibit cigarette smoke-induced hypersecretion of mucus in rat larynx and trachea in situ.
Rogers DF; Turner NC; Marriott C; Jeffery PK
Eur Respir J; 1989 Nov; 2(10):955-60. PubMed ID: 2532606
[TBL] [Abstract][Full Text] [Related]
12. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
13. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease.
Rosell A; Monsó E; Soler N; Torres F; Angrill J; Riise G; Zalacaín R; Morera J; Torres A
Arch Intern Med; 2005 Apr; 165(8):891-7. PubMed ID: 15851640
[TBL] [Abstract][Full Text] [Related]
14. The Toll-Like Receptor 5 agonist flagellin prevents Non-typeable Haemophilus influenzae-induced infection in cigarette smoke-exposed mice.
Pérez-Cruz M; Koné B; Porte R; Carnoy C; Tabareau J; Gosset P; Trottein F; Sirard JC; Pichavant M; Gosset P
PLoS One; 2021; 16(3):e0236216. PubMed ID: 33784296
[TBL] [Abstract][Full Text] [Related]
15. Experimental COPD induced by solid combustible burn smoke in rats: a study of the emphysematous changes of the pulmonary parenchyma.
Murărescu ED; Eloae-Zugun F; Mihailovici MS
Rom J Morphol Embryol; 2008; 49(4):495-505. PubMed ID: 19050798
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of new therapies for treatment of mucus hypersecretion in respiratory diseases.
Disse B
Novartis Found Symp; 2002; 248():254-72; discussion 272-6, 277-82. PubMed ID: 12568499
[TBL] [Abstract][Full Text] [Related]
17. Inhaled adrenergics and anticholinergics in obstructive lung disease: do they enhance mucociliary clearance?
Restrepo RD
Respir Care; 2007 Sep; 52(9):1159-73; discussion 1173-5. PubMed ID: 17716384
[TBL] [Abstract][Full Text] [Related]
18. Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease.
Murphy TF; Brauer AL; Schiffmacher AT; Sethi S
Am J Respir Crit Care Med; 2004 Aug; 170(3):266-72. PubMed ID: 15117742
[TBL] [Abstract][Full Text] [Related]
19. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease.
Yoshida T; Tuder RM
Physiol Rev; 2007 Jul; 87(3):1047-82. PubMed ID: 17615396
[TBL] [Abstract][Full Text] [Related]
20. A mucoactive drug carbocisteine ameliorates steroid resistance in rat COPD model.
Song Y; Yu P; Lu JJ; Lu HZ; Zhu L; Yu ZH; Chen HZ; Cui YY
Pulm Pharmacol Ther; 2016 Aug; 39():38-47. PubMed ID: 27328977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
